Celecoxib in oncology: targeting the COX-2/PGE<sub>2</sub> axis to reprogram the tumor immune microenvironment and enhance multimodal therapy. [PDF]
Kuang B +5 more
europepmc +1 more source
Recent Advances in Dual COX/LOX Inhibitor Design (2020-2024): Establishing "<i>The Rule of Four for Inflammation</i>". [PDF]
Chatzipieris FP +4 more
europepmc +1 more source
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial. [PDF]
Zhang GQ +22 more
europepmc +1 more source
Bovine serum albumin nanoparticles encapsulating Dasatinib and Celecoxib for oral cancer: Preparation, characterization, and in-vitro evaluation [PDF]
Ghadeer AbouBakr Aly +4 more
openalex +1 more source
Routine Ketorolac Use for Postoperative Pain Does Not Increase Bleeding Risk After Hysterectomy. [PDF]
Pipes GM +7 more
europepmc +1 more source
Patient burden of weight gain and blood pressure increase among RA patients using celecoxib, rofecoxib, and non-specific NSAIDs [PDF]
Frederick Wolfe
openalex +1 more source
Spectrophotometric Determination of Celecoxib in Pharmaceutical Preparations
Lamia Lafta Ghashim
openalex +1 more source
Ammonia-triggered disintegration of kappa-carrageenan hydrogel carrier for site-specific anti-inflammatory drug delivery. [PDF]
Kumar S +7 more
europepmc +1 more source
Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials [PDF]
Jonathan J Deeks +2 more
openalex +1 more source

